# Study on PhArmacokinetics of First liNe Antiretrovirals in Healthy Breastfeeding Volunteers

> **NCT05648201** · PHASE4 · COMPLETED · sponsor: **Radboud University Medical Center** · enrollment: 20 (actual)

## Conditions studied

- Hiv

## Interventions

- **DRUG:** Doravirine 100Mg Tab
- **DRUG:** Biktarvy 50/200/25 Tab

## Key facts

- **NCT ID:** NCT05648201
- **Lead sponsor:** Radboud University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-03-01
- **Primary completion:** 2024-11-01
- **Final completion:** 2025-04-28
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2026-04-16

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05648201

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05648201, "Study on PhArmacokinetics of First liNe Antiretrovirals in Healthy Breastfeeding Volunteers". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05648201. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*